Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0OZ1P
|
|||
Drug Name |
Fused aryl carbocycle derivative 9
|
|||
Synonyms |
PMID30185082-Compound-52
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
|
|||
Structure |
Download2D MOL |
|||
Formula |
C26H35N3O2
|
|||
Canonical SMILES |
CCCN1CCN(CC1)C2=CC=CC3=C2CCCC3N(C)C(=O)OCC4=CC=CC=C4
|
|||
InChI |
1S/C26H35N3O2/c1-3-15-28-16-18-29(19-17-28)25-14-8-11-22-23(25)12-7-13-24(22)27(2)26(30)31-20-21-9-5-4-6-10-21/h4-6,8-11,14,24H,3,7,12-13,15-20H2,1-2H3
|
|||
InChIKey |
YZQOEMNLUIMOMX-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] |
Target's Patent Info | Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | The sigma-2 (-2) receptor: a review of recent patent applications: 2013-2018.Expert Opin Ther Pat. 2018 Sep;28(9):655-663. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.